BENGALURU, April 25 (Reuters) - Indian drugmaker Glenmark Life Sciences (GLEM.NS), opens new tab posted its first drop in profit for six quarters on Thursday as its mainstay active pharmaceutical ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback